Insilico Medicine, Biopharmaceuticals Strike: AI Drug Deal Heads Toward $2.5B
Insilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
Looking for the best places to invest for maximum returns in 2023? Discover effective strategies to enhance your investment portfolio.
14,465 articlesInsilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
Saudi Aramco’s chairman presses policymakers to embrace energy realism as global markets wrestle with supply risks an...
A tech giant lanes three high-margin engines—cloud, ads, and subscriptions—on a profitable retail base, challenging m...
Super Micro Computer's stock has swung wildly in the AI era. This guide explains what the current valuation means, ho...
Ray Dalio wraps a 10-day China-focused Asia tour, warning that a realignment of global power could reshape markets an...
World Cup 2026 in the U.S. has sparked a spending spree among fans who travel with dreams of the tournament, even if ...
A single metric may reveal whether Nvidia will continue dominate in AI. This deep dive explains the number, the risks...
A high-yield ETF draws retiree interest, but Warren Buffett would never chase yields at the expense of long-term grow...
Investors woke up to a surge in Qualcomm stock after the company outlined bold AI-backed growth targets. This article...
Investors are increasingly circling a single dominant payments network that could redefine how money moves worldwide,...
A two-day pension fund rebalance could move about $30 billion of U.S. stocks, posing near-term volatility but often a...
When tragedy hits a family, money becomes both a tool and a stressor. This article explores practical steps to stabil...